-
Financial News
/ 3 months agoAppeals court skeptical of Trump tariff authority
Trump’s reciprocal tariffs and trafficking-related duties were previously struck down by a federal trade court, but that decision was put on...
-
Financial News
/ 3 months agoStocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more
These are the stocks posting the largest moves midday.Read More
-
Financial News
/ 3 months agoNebraska biofuels plant explosion kills 3 people, including 2 young girls
Two young girls and an adult man are dead after a huge explosion tore through a Nebraska biofuels plant, officials said...
-
Financial News
/ 3 months agoMore Americans are struggling to pay their debt: 6 ways to tackle yours now
Americans have been feeling the financial squeeze as prices continue to rise due to inflation and interest rates stay high as...
-
Financial News
/ 3 months agoShould seniors buy annuities if they have Social Security?
Between today’s issues with sticky inflation, rising healthcare costs and longer life expectancies, retirement income planning has gotten a lot more...
-
Financial News
/ 3 months ago38-year-old woman has already waited eight months in a 65,448-person backlog for Public Service Loan Forgiveness
A Biden-era program aimed at helping borrowers access the Public Service Loan Forgiveness program has stalled under the Trump administration.Read More
-
Financial News
/ 3 months agoWe’re upgrading our rating on Palo Alto as shares tumble on its $25 billion CyberArk acquisition
The stock is “getting crushed because people think they paid too much, and that’s wrong,” Jim Cramer said.Read More
-
Financial News
/ 3 months agoU.S. sanctions Brazilian judge targeted by Trump over Bolsonaro case
The sanctions come before Trump plans to impose tariffs of 50% on imports from Brazil in part because of the prosecution...
-
Financial News
/ 3 months agoTrump announces 25% tariff on India
President Trump announced Wednesday the U.S. would impose tariffs of 25% on imports from India — in addition to an unspecified...
-
Financial News
/ 3 months agoControversial vaccine official Dr. Vinay Prasad departs FDA
Dr. Vinay Prasad, the controversial FDA vaccine official who had been critical of the agency’s moves to greenlight COVID-19 boosters, has...


